Roxane Labs Recalls Azathioprine Tablets

Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

Roxane Laboratories (Columbus, OH), a Boehringer Ingelheim company, is conducting a voluntary recall in the United States and Puerto Rico of a single manufacturing lot of "Azathioprine"tablets, USP 50 mg.

Roxane Laboratories (Columbus, OH, www.roxane.com), a Boehringer Ingelheim company,is conducting a voluntary recall in the United States and Puerto Ricoof a single manufacturing lot of azathioprine tablets, USP 50 mg. Thecompany ordered the recall after discovering that a single bottleof azathioprine, which had not been dispensed to a patient, containedMethotrexate tablets, USP 2.5 mg, which would cause "serious toxiceffects" and even death at high doses, if taken in accordance withdosing instructions that may be prescribed for azathioprine. The companyis working with FDA on this recall, and no related injuries have beenreported to date.

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content